Patients with a rheumatic disease are at a higher risk for infection due to their disease or medications. Dr. Chris Mecoli from the Division of Rheumatology speaks with Dr. Erika Darrah about steps a patient could take in order to prevent infections.
Raynaud’s Phenomenon is a condition that results in decreased blood flow to your fingers and toes. There are two types of Raynaud’s, primary and secondary. Dr. Zsuzsanna McMahan from the Johns Hopkins Scleroderma Center dives into what this condition is, things to look out for, how to manage and when you should speak with a doctor.
Johns Hopkins Rheumatologist Dr. Zsuzsanna McMahan shares what Scleroderma is.
In the second of our five part series on Scleroderma, Johns Hopkins Rheumatologist Dr. Zsuzsanna McMahan discusses the signs and symptoms of Scleroderma.
Johns Hopkins Rheumatologist Dr. Zsuzsanna McMahan discusses how Scleroderma is diagnosed.
In this fourth video of our series on Scleroderma, Johns Hopkins Rheumatologist Johns Hopkins Rheumatologist Dr. Zsuzsanna McMahan shares how Scleroderma is treated.
In this fifth and final part of our series on Scleroderma, Johns Hopkins Rheumatologist Dr. Zsuzsanna McMahan discusses living with Scleroderma.
Scleroderma Associated Myopathy is a muscle disease that Scleroderma patients can develop. Unfortunately, there isn’t very much knowledge about this kind of Myopathy, but the Johns Hopkins Rheumatology Division is working to understand more about this disease. Dr. Julie Paik, Assistant Professor of Medicine at Johns Hopkins Rheumatology, explains the complicated nature of this disease.
The typical symptoms that present in Scleroderma Associated Myopathy are muscle weakness, muscle fatigue, muscle pain, muscle endurance issues, and shortness of breath because of diaphragmatic weakness and cardio involvement. Dr. Julie Paik, Assistant Professor of Medicine at Johns Hopkins Rheumatology, explains the symptoms of Scleroderma Associated Myopathy.
Scleroderma Associated Myopathy is a muscle disease that Scleroderma patients can develop. Unfortunately, there isn’t very much knowledge about this kind of Myopathy, but the Johns Hopkins Rheumatology Division is working to understand more about this disease. Dr. Julie Paik, Assistant Professor of Medicine at Johns Hopkins Rheumatology, explains the complicated nature of this disease.
The treatment for Scleroderma Associated Myopathy is still largely unknown because there is not enough information about the disease. The Johns Hopkins Rheumatology Division is working to understand more about this kind of Myopathy. In this video, Dr. Julie Paik, Assistant Professor of Medicine at Johns Hopkins Rheumatology, explains the complicated nature of treating this disease.
Treatment, a healthy lifestyle, and moderate exercise are key to getting back to normal after a diagnosis of Scleroderma Associated Myopathy. In the last episode of this five-part video series, Dr. Julie Paik, Assistant Professor of Medicine at Johns Hopkins Rheumatology, explains how remission is possible in patients with this disease.